The Alliance for Regenerative Medicine to Host FDA Representatives for Webinar on Clinical Trial Guidance During COVID-19 on April 10, 2020

Washington, DC, April 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM) today announced it will host a webinar on clinical trial guidance during the ongoing COVID-19 pandemic, with speakers from the U.S. Food and Drug Administrations (FDA) Office of Tissues and Advanced Therapies (OTAT).